These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17977031

  • 1. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
    Perruccio K, Topini F, Tosti A, Carotti A, Aloisi T, Aversa F, Martelli MF, Velardi A.
    Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
    [Abstract] [Full Text] [Related]

  • 2. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK, Giver CR, Rosenthal H, Somani J, Langston AA, Lonial S, Roback JD, Li JM, Hossain MS, Redei I.
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [Abstract] [Full Text] [Related]

  • 3. Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT.
    Perruccio K, Topini F, Tosti A, Carotti A, Burchielli E, Ruggeri L, Mancusi A, Urbani E, Aversa F, Martelli MF, Velardi A.
    Bone Marrow Transplant; 2012 Sep; 47(9):1196-200. PubMed ID: 22139067
    [Abstract] [Full Text] [Related]

  • 4. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
    Davies JK, Koh MB, Lowdell MW.
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
    [Abstract] [Full Text] [Related]

  • 5. Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.
    Hartwig UF, Nonn M, Khan S, Link I, Huber C, Herr W.
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):99-109. PubMed ID: 18158966
    [Abstract] [Full Text] [Related]

  • 6. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T, Lang P, Hamprecht K, Schumm M, Greil J, Jahn G, Niethammer D, Einsele H.
    Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
    [Abstract] [Full Text] [Related]

  • 7. T-cell therapy after hematopoietic stem cell transplantation.
    Kennedy-Nasser AA, Brenner MK.
    Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
    [Abstract] [Full Text] [Related]

  • 8. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T, Richard C, Joachim S, Scheible MH, Schumm M, Hamprecht K, Martin D, Jahn G, Handgretinger R, Lang P.
    J Immunother; 2008 Nov; 31(2):199-206. PubMed ID: 18481389
    [Abstract] [Full Text] [Related]

  • 9. Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells.
    Mackinnon S, Thomson K, Verfuerth S, Peggs K, Lowdell M.
    Blood Cells Mol Dis; 2008 Nov; 40(1):63-7. PubMed ID: 17869548
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP, Rizzieri DA, Chao NJ.
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [Abstract] [Full Text] [Related]

  • 11. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
    Micklethwaite K, Hansen A, Foster A, Snape E, Antonenas V, Sartor M, Shaw P, Bradstock K, Gottlieb D.
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
    [Abstract] [Full Text] [Related]

  • 12. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis.
    Koh MB, Prentice HG, Lowdell MW.
    Bone Marrow Transplant; 1999 May; 23(10):1071-9. PubMed ID: 10373075
    [Abstract] [Full Text] [Related]

  • 13. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M, Herr W, Khan S, Todorova M, Link I, Thies J, Distler E, Kaltwasser M, Hoffmann J, Huber C, Hartwig UF.
    Transplantation; 2008 Nov 27; 86(10):1427-35. PubMed ID: 19034014
    [Abstract] [Full Text] [Related]

  • 14. Large-scale generation of human allodepleted anti-3rd party lymphocytes.
    De Ioanni M, Di Ianni M, Bonifacio E, Moretti L, Cecchini D, Bazzucchi F, Terenzi A, Aloisi T, Falzetti F, Aversa F, Reisner Y, Martelli MF, Tabilio A.
    Blood Cells Mol Dis; 2008 Nov 27; 40(1):106-12. PubMed ID: 17931916
    [Abstract] [Full Text] [Related]

  • 15. T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors.
    Comoli P, Schilham MW, Basso S, van Vreeswijk T, Bernardo ME, Maccario R, van Tol MJ, Locatelli F, Veltrop-Duits LA.
    J Immunother; 2008 Nov 27; 31(6):529-36. PubMed ID: 18528302
    [Abstract] [Full Text] [Related]

  • 16. Current status of haploidentical stem cell transplantation.
    Dey BR, Spitzer TR.
    Br J Haematol; 2006 Nov 27; 135(4):423-37. PubMed ID: 16984391
    [Abstract] [Full Text] [Related]

  • 17. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, Handgretinger R, Peters C, Schuster FR, Beck R, Schumm M, Lotfi R, Jahn G, Lang P.
    Br J Haematol; 2006 Jul 27; 134(1):64-76. PubMed ID: 16803570
    [Abstract] [Full Text] [Related]

  • 18. In vitro methotrexate as a practical approach to selective allodepletion.
    Sathe A, Ortega SB, Mundy DI, Collins RH, Karandikar NJ.
    Biol Blood Marrow Transplant; 2007 Jun 27; 13(6):644-54. PubMed ID: 17531774
    [Abstract] [Full Text] [Related]

  • 19. Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
    Tey SK, Dotti G, Rooney CM, Heslop HE, Brenner MK.
    Biol Blood Marrow Transplant; 2007 Aug 27; 13(8):913-24. PubMed ID: 17640595
    [Abstract] [Full Text] [Related]

  • 20. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
    Feuchtinger T, Richard C, Pfeiffer M, Neuhäuser F, Lücke J, Handgretinger R, Greil J, Bader P, Klingebiel T, Schlegel PG, Jahn G, Niethammer D, Lang P.
    Klin Padiatr; 2005 Aug 27; 217(6):339-44. PubMed ID: 16307420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.